Status:
COMPLETED
Study in Patients With COPD
Lead Sponsor:
Dey
Conditions:
COPD
Eligibility:
All Genders
40+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine the efficacy and safety of the investigational drug in the treatment of COPD in comparison with a placebo.
Eligibility Criteria
Inclusion
- Medical diagnosis of COPD
- Current or prior history of cigarette smoking
Exclusion
- Medical diagnosis of asthma
- Chest x-ray (CXR) prior to Day 1 diagnostic of significant disease other than COPD
- Significant condition or disease other than COPD
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
April 1 2006
Estimated Enrollment :
690 Patients enrolled
Trial Details
Trial ID
NCT00215449
End Date
April 1 2006
Last Update
November 11 2010
Active Locations (68)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Bessemer, Alabama, United States, 35023
2
Research Site
Birmingham, Alabama, United States, 35209
3
Research Site
Phoenix, Arizona, United States, 85006-2666
4
Research Site
Tuscon, Arizona, United States, 85715